Eli Lilly’s 4Q Earnings Beat, Revenue Outlook Lowered
Eli Lilly & Company ( LLY ) reported fourth-quarter 2014 adjusted earnings per share of 75 cents, a penny above the Zacks Consensus Estimate and the year-ago earnings. Eli Lilly and Company – Quarterly EPS | FindTheBest Fourth-quarter revenues fell 12% to $5.121 billion, reflecting generic competition for Cymbalta and Evista in the U.S. as well as negative currency movement […]